Addressing Key Challenges
in Cell Therapy
Target Space
Our approaches combine biological and engineering insights to enable target-unlock without the risk and complexity of additional gene editing.
Cell Quality
By minimizing cell manipulation and intensely focusing on cell quality during production, our team is dedicated to ensuring the underlying engine of our cell therapies achieves peak function.
Manufacturing
We assembled a team of technical development and cell therapy specialists to ensure the robust and efficient production of high-quality CAR-T cells.
Our Mission
We are dedicated to revolutionizing patient care by unlocking new targets for challenging indications. To meet this goal, we have developed a team of innovators possessing extensive drug development experience and highly specialized in the cell therapy field
Our First Product
MB-105 is designed to drive impact in highly unmet clinical needs, T- cell lymphoma:
10-20% Of Patients
with relapsed / refractory T-cell lymphoma will survive 3 years
Narrow therapeutic options
leave patients with reduced chances of positive outcomes
Limited drug development
for on-target, off-tumor toxicity
Play Video
Our Team
We have a deep, seasoned leadership team with more than 20 years of experience in the cell therapy field.
Previous
Next
News & Publications
Read more about how March Biosciences’ research has impacted the medical community.